NCT06651593 2026-03-24
Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors
M.D. Anderson Cancer Center
Phase 2 Recruiting
M.D. Anderson Cancer Center
Shandong Suncadia Medicine Co., Ltd.
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran